TNF and Parkinson disease: Moreover, miR-30e was reported to attenuate the levels of inflammatory cytokines, such as TNF-α, COX-2, and iNOS, and ameliorate neuroinflammation in a MPTP model of PD through directly targeting the NLRP3 inflammasome [30].